Racial disparities among patients with lung cancer who were recommended operative therapy

Archives of Surgery

Volumn 144, Issue 1, 2009, Pages 14-18

  Farjah, Farhood ^a   Wood, Douglas E ^b   Yanez III, N David ^a   Vaughan, Thomas L ^c   Symons, Rebecca Gaston ^a   Krishnadasan, Bahirathan ^b,d   Flum, David R ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

^d St Joseph Hospital Tacoma   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HEALTH CARE PERSONNEL; HEALTH CARE SYSTEM; HUMAN; LUNG CANCER; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT CARE; PRIORITY JOURNAL; RACE DIFFERENCE; TREATMENT OUTCOME;

AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; COHORT STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTHCARE DISPARITIES; HUMANS; LUNG NEOPLASMS; MALE; PNEUMONECTOMY; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 58749101698     PISSN: 00040010     EISSN: 15383644     Source Type: Journal    
DOI: 10.1001/archsurg.2008.519     Document Type: Article

References (31)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin. 2007;57(1):43-66.
2. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology, v.2.2008: non-small cell lung cancer. http://www.nccn.org/ professionals/physician-gls/PDF/nscl.pdf. Accessed January 2008.
3. Scott WJ, Howington J, Movsas B. Treatment of stage II non-small cell lung cancer. Chest. 2003;123(1)(suppl):188S-201S.
4. Smythe WR. Treatment of stage I non-small cell lung carcinoma. Chest. 2003;123(1)(suppl):181S-187S.
5. Bach PB, Cramer LD, Warren JL, Begg CB. Racial differences in the treatment of early-stage lung cancer. N Engl J Med. 1999;341(16):1198- 1205.
6. Shavers VL, Brown ML. Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst. 2002;94(5):334-357.
7. Jazieh AR, Kyasa MJ, Sethuraman G, Howington J. Disparities in surgical resection of early-stage non-small cell lung cancer. J Thorac Cardiovasc Surg. 2002;123(6):1173-1176.
8. Mulligan CR, Meram AD, Proctor CD, Wu H, Zhu K, Marrogi AJ. Unlimited access to care: effect on racial disparity and prognostic factors in lung cancer. Cancer Epidemiol Biomarkers Prev. 2006;15(1):25-31.
9. McCann J, Artinian V, Duhaime L, Lewis JW Jr, Kvale PA, DiGiovine B. Evaluation of the causes for racial disparity in surgical treatment of early stage lung cancer. Chest. 2005;128(5):3440-3446.
10. Margolis ML, Christie JD, Silvestri GA, Kaiser L, Santiago S, Hansen-Flaschen J. Racial differences pertaining to a belief about lung cancer surgery: results of a multicenter survey. Ann Intern Med. 2003;139(7):558-563.
11. Cykert S, Phifer N. Surgical decisions for early stage, non-small cell lung cancer: which racially sensitive perceptions of cancer are likely to explain racial variation in surgery? Med Decis Making. 2003;23(2):167-176.
12. Gordon HS, Street RL Jr, Sharf BF, Kelly PA, Souchek J. Racial differences in trust and lung cancer patients' perceptions of physician communication. J Clin Oncol. 2006;24(6):904-909.
13. Gordon HS, Street RL Jr, Sharf BF, Souchek J. Racial differences in doctors' information-giving and patients' participation. Cancer. 2006;107(6):1313-1320.
14. Smedley BD, Stith AY, Nelson AR, eds. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care. Washington, DC: National Academies Press; 2003.
15. Bach PB. Racial disparities and site of care. Ethn Dis. 2005;15(2)(suppl 2):S31-S33.
16. National Cancer Institute. SEER-Medicare linked database. http://healthservices.cancer.gov/seermedicare/. Accessed May 17, 2007.
17. Bach PB, Guadagnoli E, Schrag D, Schussler N, Warren JL. Patient demographic and socioeconomic characteristics in the SEER-Medicare database applications and limitations. Med Care. 2002;40(8)(suppl):IV-19-IV-25.
18. Cooper GS, Virnig B, Klabunde CN, Schussler N, Freeman J, Warren JL. Use of SEER-Medicare data for measuring cancer surgery. Med Care. 2002;40(8)(suppl):IV-43-IV-48.
19. Klabunde CN, Warren JL, Legler JM. Assessing comorbidity using claims data: an overview. Med Care. 2002;40(8)(suppl):IV-26-IV-35.
20. Virnig BA, Warren JL, Cooper GS, Klabunde CN, Schussler N, Freeman J. Studying radiation therapy using SEER-Medicare-linked data. Med Care. 2002;40(8)(suppl):IV-49-IV-54.
21. Warren JL, Harlan LC, Fahey A, et al. Utility of the SEER-Medicare data to identify chemotherapy use. Med Care. 2002;40(8)(suppl):IV-55-IV-61.
22. Warren JL, Klabunde CN, Schrag D, Bach PB, Riley GF. Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care. 2002;40(8)(suppl):IV-3-IV-18.
23. Johnson CH, ed. The SEER Program Coding and Staging Manual 2004, revision 1. http://seer.cancer.gov/manuals/2004Revision%201/SPM-2004-maindoc.r1.pdf. Accessed February 28, 2008.
24. Klabunde CN, Potosky AL, Legler JM, Warren JL. Development of a comorbidity index using physician claims data. J Clin Epidemiol. 2000;53(12):1258-1267.
25. American Joint Committee on Cancer. Cancer Staging Manual. Greene FL, Page DL, Fleming ID, et al, eds; 6th ed. New York, NY: Springer; 2002.
26. World Health Organization. International Classification of Diseases, Ninth Revision (ICD-9). Geneva, Switzerland: World Health Organization; 1977.
27. Zhang J, Yu KF. What's the relative risk? a method of correcting the odds ratio in cohort studies of common outcomes. JAMA. 1998;280(19):1690- 1691.
28. Little AG, Gay EG, Gaspar LE, Stewart AK. National survey of non-small cell lung cancer in the United States: epidemiology, pathology and patterns of care. Lung Cancer. 2007;57(3):253-260.
29. Bach PB, Pham HH, Schrag D, Tate RC, Hargraves JL. Primary care physicians who treat blacks and whites. N Engl J Med. 2004;351(6):575-584.
30. Epstein AM, Ayanian JZ, Keogh JH, et al. Racial disparities in access to renal transplantation: clinically appropriate or due to underuse or overuse? N Engl J Med. 2000;343(21):1537-1544.
31. Wisnivesky JP, McGinn T, Henschke C, Hebert P, Iannuzzi MC, Halm EA. Ethnic disparities in the treatment of stage I non-small cell lung cancer. Am J Respir Crit Care Med. 2005;171(10):1158-1163.